Literature DB >> 10790203

RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems.

R M Hofstra1, Y Wu, R P Stulp, P Elfferich, J Osinga, S M Maas, L Siderius, A S Brooks, J J vd Ende, V M Heydendael, R S Severijnen, K M Bax, C Meijers, C H Buys.   

Abstract

Hirschsprung disease (HSCR) is a congenital disorder characterised by intestinal obstruction due to an absence of intramural ganglia along variable lengths of the intestine. RET is the major gene involved in HSCR. Mutations in the GDNF gene, and encoding one of the RET ligands, either alone or in combination with RET mutations, can also cause HSCR, as can mutations in four other genes (EDN3, EDNRB, ECE1, and SOX10). The rare mutations in the latter four genes, however, are more or less restricted to HSCR associated with specific phenotypes. We have developed a novel comprehensive mutation detection system to analyse all but three amplicons of the RET and GDNF genes, based on denaturing gradient gel electrophoresis. We make use of two urea-formamide gradients on top of each other, allowing mutation detection over a broad range of melting temperatures. For the three remaining (GC-rich) PCR fragments we use a combination of DGGE and constant denaturing gel electrophoresis (CDGE). These two dual gel systems substantially facilitate mutation scanning of RET and GDNF, and may also serve as a model to develop mutation detection systems for other disease genes. In a screening of 95 HSCR patients, RET mutations were found in nine out of 17 familial cases (53%), all containing long segment HSCR. In 11 of 78 sporadic cases (14%), none had long segment HSCR. Only one GDNF mutation was found, in a sporadic case. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790203     DOI: 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

Review 1.  Total colonic aganglionosis and Hirschsprung's disease: a review.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2014-10-31       Impact factor: 1.827

2.  Association study of PHOX2B as a candidate gene for Hirschsprung's disease.

Authors:  M Garcia-Barceló; M H Sham; V C H Lui; B L S Chen; J Ott; P K H Tam
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

Review 3.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

4.  Hirschsprung's disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation.

Authors:  Tonia C Carter; Denise M Kay; Marilyn L Browne; Aiyi Liu; Paul A Romitti; Devon Kuehn; Mary R Conley; Michele Caggana; Charlotte M Druschel; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2012-05-31       Impact factor: 3.172

Review 5.  Enteric nervous system development: A crest cell's journey from neural tube to colon.

Authors:  Nandor Nagy; Allan M Goldstein
Journal:  Semin Cell Dev Biol       Date:  2017-01-10       Impact factor: 7.727

Review 6.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

7.  A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3-q32.3.

Authors:  A S Brooks; P A Leegwater; G M Burzynski; P J Willems; B de Graaf; I van Langen; P Heutink; B A Oostra; R M W Hofstra; A M Bertoli-Avella
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

8.  Identifying candidate Hirschsprung disease-associated RET variants.

Authors:  Grzegorz M Burzynski; Ilja M Nolte; Agnes Bronda; Krista K Bos; Jan Osinga; Ivan Plaza Menacho; Bas Twigt; Saskia Maas; Alice S Brooks; Joke B G M Verheij; Charles H C M Buys; Robert M W Hofstra
Journal:  Am J Hum Genet       Date:  2005-03-09       Impact factor: 11.025

9.  Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.

Authors:  Marta Rusmini; Paola Griseri; Francesca Lantieri; Ivana Matera; Kelly L Hudspeth; Alessandra Roberto; Joanna Mikulak; Stefano Avanzini; Valentina Rossi; Girolamo Mattioli; Vincenzo Jasonni; Roberto Ravazzolo; William J Pavan; Alessio Pini-Prato; Isabella Ceccherini; Domenico Mavilio
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

10.  Fine mapping of the 9q31 Hirschsprung's disease locus.

Authors:  C S Tang; Y Sribudiani; X P Miao; A R de Vries; G Burzynski; M T So; Y Y Leon; B H Yip; J Osinga; K J W S Hui; J B G M Verheij; S S Cherny; P K H Tam; P C Sham; R M W Hofstra; M M Garcia-Barceló
Journal:  Hum Genet       Date:  2010-04-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.